Transgene Biotek Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	236	150	254	617	189	274
Market Cap Growth	-25.60%	-40.90%	-58.85%	226.91%	-31.03%	-21.18%
Enterprise Value	406	314	393	752	314	390
Last Close Price	3.11	1.98	3.35	8.14	2.49	3.61
PS Ratio	65.26	41.55	97.37	262.57	342.41	315.51
PB Ratio	2.81	1.79	2.53	5.76	1.66	1.57
P/TBV Ratio	12.81	8.16	7.28	14.82	3.92	4.59
P/FCF Ratio	-	-	-	13408.00	-	279.68
P/OCF Ratio	-	-	21.23	13408.00	94333.65	279.68
EV/Sales Ratio	112.55	87.09	150.87	320.27	569.87	449.30
EV/FCF Ratio	-	-	-	16354.75	-	398.27
Debt / Equity Ratio	2.05	2.05	1.45	1.31	1.15	0.69
Debt / FCF Ratio	-	-	-	3043.70	-	122.78
Net Debt / Equity Ratio	2.04	2.04	1.42	1.31	1.15	0.69
Net Debt / EBITDA Ratio	-43.38	-43.38	-12.68	-23.09	-12.45	-26.01
Net Debt / FCF Ratio	-1511.15	-1511.15	-28.26	3042.02	-10084.15	122.62
Asset Turnover	0.00	0.00	0.00	0.00	0	0.00
Inventory Turnover	-	-	-	0.09	1.03	-
Quick Ratio	0.01	0.01	0.02	0.00	0.00	0.00
Current Ratio	0.08	0.08	0.10	0.10	0.10	0.08
Return on Equity (ROE)	-17.96%	-17.96%	-6.52%	-5.94%	-41.80%	-52.51%
Return on Assets (ROA)	-0.26%	-0.26%	-0.53%	-0.31%	-2.59%	-4.27%
Return on Capital Employed (ROCE)	-0.50%	-0.50%	-0.90%	-0.50%	-4.60%	-7.50%
Earnings Yield	-7.01%	-11.02%	-2.66%	-1.06%	-31.85%	-38.03%
FCF Yield	-	-0.07%	-1.98%	0.01%	-0.01%	0.36%
Buyback Yield / Dilution	0.84%	0.84%	-	-	-	-